Q1 2022 Erytech Pharma SA Earnings Call Transcript
Good day and thank you for standing by. Welcome to Erytech business update and financial highlights for the first quarter of 2022 conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to Gil Beyen, Chief Executive Officer. Mr. Beyen, please go ahead.
Thank you, Norma. Good afternoon, good morning, bonjour à tous. Thank you for joining this conference call to discuss the key business highlights year to date and the financials for the first three months of this year.
We announced our business and financial update yesterday evening and the press release, also the webcast presentation, can be found on the Investor Relations page of our website. Joining me on the call today are Dr. Iman El-Hariry, our Chief Medical Officer; and Eric Soyer, our Chief Financial and Chief Operating Officer.
Before starting on slide 2, I'd like to draw your attention to the disclaimer, reminding you that today's call
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
